Subcortical White Matter Lesions: What Do They Mean?

Subcortical white matter lesions are bright spots that show up on brain MRI scans, usually reflecting damage to the brain’s wiring from chronic small vessel disease, aging, or a combination of both. In most people over 60, they are common enough to be considered part of normal aging, but their size and location matter. A few scattered spots in someone over 70 carry a very different meaning than a heavy load of lesions in a 50-year-old. Understanding what drives them, which cognitive and physical abilities they can erode, and what you can actually do about them requires looking well beyond the radiology report.

What Shows Up on the Scan and What It Actually Represents

On a standard brain MRI, subcortical white matter lesions appear as bright areas on sequences called T2 and FLAIR. Radiologists sometimes call them white matter hyperintensities, or WMH. The brightness comes from increased water content in the tissue, which can reflect several things happening at once: damage to the insulating sheath around nerve fibers, scarring from chronic low-grade inflammation, or simply fluid leaking from aging blood vessels. A radiologic-neuropathologic study comparing MRI findings with actual brain tissue found that these bright spots can overestimate damage in some regions and underestimate it in others. Periventricular lesions (those near the fluid-filled ventricles at the brain’s center) often looked worse on MRI than the tissue damage warranted, likely because of leaky blood vessels raising the local water content. Meanwhile, lesions deeper in the white matter were sometimes more severe under the microscope than the scan suggested.

1PubMed Central. Do brain T2/FLAIR white matter hyperintensities correspond to myelin loss in normal aging? A radiologic-neuropathologic correlation study

This distinction matters. A bright spot near the ventricles and a bright spot deep in the brain’s white matter are not the same thing biologically. Periventricular lesions tend to involve loosening of nerve fiber bundles, scarring, and loss of the myelin coating, and they are strongly linked to blood pressure. Deep white matter lesions are more varied in their underlying tissue damage, often involving both nerve fiber loss and thickening of tiny artery walls, and they associate more with body mass index than with blood pressure alone.

2NeuroImage. Classification and characterization of periventricular and deep white matter hyperintensities on MRI: A study in older adults

Why They Form in Different Brain Regions

The periventricular zone and the deep white matter get their blood supply through different systems of tiny vessels, and those systems can fail in different ways. Periventricular lesions appear to be driven largely by damage to small veins and by dysfunction of the brain’s waste-clearance system, sometimes called the glymphatic pathway. Deep lesions are influenced by that same waste-clearance problem but also by reduced blood flow and chronic oxygen deprivation from stiffened, narrowed arterioles.

3PubMed Central. Different mechanisms in periventricular and deep white matter hyperintensities in old subjects

At the core of most cases is a condition called cerebral small vessel disease. The tiny arteries feeding the brain’s white matter develop thickened walls, narrowed or blocked passageways, and weakened barriers between the blood and the surrounding tissue. The hallmark changes in the vessel walls go by names like arteriolosclerosis and lipohyalinosis, and the primary driver of those changes is hypertension.

4The Lancet Neurology. Small vessel disease: mechanisms and clinical implications

A related finding reinforces this picture. The blood-brain barrier, the tightly sealed layer that normally prevents blood components from seeping into brain tissue, becomes leakier in areas surrounding existing white matter lesions. A longitudinal study found that the degree of blood-brain barrier leakage at baseline predicted how much the surrounding tissue deteriorated over the next two years, suggesting that barrier breakdown is not just a bystander but an early driver of the damage spreading outward from existing lesions.

5PubMed Central. Baseline Blood-Brain Barrier Leakage and Longitudinal Microstructural Tissue Damage in the Periphery of White Matter Hyperintensities

How Common They Are and How They Change With Age

White matter lesions become dramatically more common as you age. In a large imaging study, their prevalence rose significantly with each decade after 40, with each age group showing a statistically higher rate than the one before it.

6PubMed Central. Prevalence of white matter hyperintensities increases with age

The volume of these lesions grows as well, and it does so exponentially. A large pooled analysis of over 14,800 people from 15 population cohorts found that white matter lesion volume roughly doubles every ten years in both men and women. Women tended to accumulate higher volumes than men starting around age 40, with the gap widening at older ages, equivalent to roughly two extra years of aging between 40 and 70 and up to five extra years above age 80.

7Neurobiology of Aging. Cerebral white matter hyperintensity volumes: Normative age- and sex-specific values from 15 population-based cohorts comprising 14,876 individuals

A seven-year follow-up study of healthy middle-aged and older adults confirmed that this growth accelerates with advanced age and that people who already have a higher burden of lesions tend to accumulate more, faster. The study also found that among the cognitive abilities tested, slowing of perceptual speed was the ability most linked to faster lesion progression.

8PubMed. Seven-year progression of white matter hyperintensities and age-related cognitive change in healthy middle-aged and older adults

The Cognitive Toll

The relationship between white matter lesions and cognitive decline is well established but selective. These lesions do not uniformly erode all thinking abilities. The cognitive domains most consistently affected are executive function (planning, mental flexibility, organizing tasks) and processing speed. A study in a general elderly population found that a larger volume of white matter lesions was related to worse executive function, motor speed, and overall cognition but was not significantly related to memory or information processing speed.

9JAMA Psychiatry. White Matter Microstructural Integrity and Cognitive Function in a General Elderly Population

Memory problems can emerge, but they appear to be an indirect consequence. Research has shown that the influence of white matter lesions on episodic memory (your ability to recall personal experiences and events) is mediated through their effect on executive functioning. In other words, the lesions impair the organizational and retrieval processes that help you access memories, rather than damaging the memory storage itself. The hippocampus, the brain’s primary memory structure, interacts with executive function in a way that can either worsen or buffer the memory impact.

10PubMed Central. Executive function mediates effects of white matter hyperintensities on episodic memory

Location also matters for cognition. Higher white matter lesion volume has been independently associated with lower scores on both executive function and episodic memory tasks, with the specific location of lesions helping to determine which ability is most affected.

11PubMed Central. Correlations between MRI white matter lesion location and executive function and episodic memory

Physical Effects Beyond Thinking

White matter lesions do not just affect cognition. They also impair the brain’s ability to coordinate movement. A systematic review found consistent evidence that greater lesion volumes are associated with impaired balance, slower walking speed, and reduced overall mobility. The relationship was strongest for lesions in the frontal lobe and periventricular regions. Falls were a particular concern, though the risk appeared to follow a threshold pattern: only people with severe lesion volumes were at significantly increased risk of falling, while those with mild or moderate loads were not clearly at higher risk.

12PubMed. Impact of white matter lesions on physical functioning and fall risk in older people: a systematic review

The gait connection is particularly well-studied. Both white matter hyperintensities and lower integrity of the normal-appearing white matter around them contribute to slower walking speed in older adults.

13PubMed Central. Cerebral White Matter and Slow Gait: Contribution of Hyperintensities and Normal-appearing Parenchyma

The Depression Connection

One of the more surprising implications of subcortical white matter lesions is their link to depression in older adults. People with severe subcortical white matter lesions were found to be about three and a half times more likely to have a history of depression that first appeared after age 60, compared with people who had mild or no lesions. This association was specific to subcortical lesions; periventricular lesions did not carry the same risk.

14JAMA Psychiatry. Cerebral White Matter Lesions and Depressive Symptoms in Elderly Adults

This finding helped shape the concept of “vascular depression,” the idea that damage to the brain’s small vessels can disrupt mood-regulating circuits and produce depression that looks clinically similar to other forms but has a distinct underlying cause. Late-onset depression that appears alongside white matter lesions on a brain scan can be harder to treat with standard antidepressants, which makes recognizing the vascular contribution clinically useful rather than merely academic.

Stroke and Vascular Event Risk

White matter lesions are not just a marker of past small vessel wear. They predict future vascular events, especially stroke. The Rotterdam Scan Study, a large population-based study, found that people in the highest third of the white matter lesion distribution had a stroke risk roughly four to five times higher than those in the lowest third.

15PubMed. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study

A French study of older adults confirmed this, finding that stroke risk was multiplied by five for those in the highest quarter of white matter lesion volume, and that lesions were an independent predictor of stroke after accounting for traditional risk factors.

16PubMed. Cerebral white matter lesions are associated with the risk of stroke but not with other vascular events: the 3-City Dijon Study

In people who have already had a transient ischemic attack (a brief stroke-like episode that resolves), lesion volume also predicted recurrence. Those in the highest quarter of lesion volume had roughly an eightfold elevation in the risk of a subsequent vascular event compared with those in the lowest quarter.

17PubMed Central. White Matter Lesions Predict Recurrent Vascular Events in Patients with Transient Ischemic Attacks

When Lesions Are Not Just Aging

While small vessel disease and aging account for most white matter lesions in older adults, the same kind of bright spots on an MRI can also show up in conditions that demand very different treatment. Distinguishing between causes is one of the trickiest parts of interpreting these scans.

Multiple sclerosis is the classic mimic. MS lesions and small vessel disease lesions can look similar, especially when both occur in periventricular regions. A distinguishing feature of MS is the Dawson’s finger sign, where lesions extend outward from the ventricles in finger-like projections, but not all MS lesions show this pattern.

18PubMed Central. White matter disease derived from vascular and demyelinating origins

Advanced MRI techniques are being explored to help tell them apart. A study using synthetic MRI found that white matter lesions in MS had lower myelin content and higher water concentration than similar-looking lesions from stroke, though simply knowing the patient’s age was itself a strong differentiator, reflecting the reality that MS typically presents younger.

19PubMed Central. Pathological signatures of white matter lesions in multiple sclerosis versus stroke: a synthetic MRI study

Antiphospholipid syndrome, an autoimmune clotting disorder, can also produce scattered subcortical white matter lesions that closely mimic MS on MRI, making differentiation challenging.

20Multiple Sclerosis and Related Disorders. Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases

CADASIL is a rare inherited condition that deserves mention because it is the most common single-gene cause of stroke and vascular dementia, and it produces extensive white matter lesions that can look like aggressive age-related small vessel disease in someone far too young for that diagnosis. It is caused by mutations in the NOTCH3 gene, and it typically announces itself with migraine with aura, recurrent small strokes, mood disturbances, and progressive dementia.

21PubMed Central. A New NOTCH3 Gene Mutation Associated With a CADASIL (Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy) Diagnosis

Migraine itself is associated with more white matter lesions, particularly in people who experience aura. A study found that people with migraine with aura had significantly more lesions than those with migraine without aura. These migraine-related lesions are generally small and scattered, and current evidence does not clearly show they lead to the same clinical consequences as the larger, confluent lesions of small vessel disease. Still, their presence on a scan can add confusion to interpretation.

22PubMed Central. Relation between migraine pattern and white matter hyperintensities in brain magnetic resonance imaging

How Lesions Are Graded

Radiologists commonly use the Fazekas scale, a visual grading system that scores periventricular and deep white matter lesions separately on a scale from 0 (none) to 3 (large confluent areas). This approach has been used for decades and is simple to apply, but it is inherently coarse. Automated volumetric tools that measure the exact volume of lesions in cubic centimeters are increasingly available and can track changes more precisely over time. Studies comparing the two methods find good agreement: automated volume measurements increase in a stepwise fashion across Fazekas categories, supporting that the visual scale captures real differences in lesion burden.

23PubMed Central. Quantifying White Matter Hyperintensities: Automated Volumetry Compared with Visual Grading Scales

One important point about grading: white matter lesion burden does not map cleanly onto Alzheimer’s disease pathology. A study examining whether Fazekas scores could inform about the presence of amyloid or tau protein buildup (the hallmark changes of Alzheimer’s) found poor correlation between the two. White matter lesions and Alzheimer’s pathology can co-exist, especially in older people, but a heavy lesion load does not by itself indicate Alzheimer’s disease.

24PubMed Central. Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer’s disease pathology in the population?

What You Can Do About Them

The most actionable lever for slowing white matter lesion progression is blood pressure control, and aggressive control appears to work better than standard targets. The SPRINT MIND trial, which compared a systolic blood pressure target below 120 mmHg against a standard target below 140 mmHg, found that the intensive treatment group had a significantly smaller increase in white matter lesion volume over the follow-up period. The difference was modest in absolute terms, but it was consistent and statistically clear.

25JAMA. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions

Population-based data reinforce the point from a different angle. People with uncontrolled, untreated hypertension had significantly more lesion progression per year than those whose hypertension was treated, even if the treated group’s blood pressure was still above ideal levels. Simply being on medication reduced progression, and better control reduced it further.

26PubMed. High blood pressure and cerebral white matter lesion progression in the general population

Blood sugar control appears relevant too. Both pre-diabetes and diabetes are associated with higher white matter lesion volumes even after accounting for other cardiovascular risk factors. The association was driven by post-meal blood sugar spikes rather than fasting glucose levels, which suggests that the type of glucose dysregulation matters.

27BMJ Open Open Access. White matter hyperintensity volume in pre-diabetes, diabetes and normoglycemia

An intriguing question is whether lesions can actually shrink. Most of the time, progression is the rule. But studies tracking lesion volume over time have documented apparent regression in some people. This could reflect real biology, such as the resolution of swelling or fluid around a lesion, but it could also be a measurement artifact from scan-to-scan technical variability. Blood pressure lowering is the only intervention shown in a clinical trial to reduce the rate of new lesion accumulation; whether it can reverse existing damage remains uncertain.

28PubMed Central. How often does white matter hyperintensity volume regress in cerebral small vessel disease?

Blood Biomarkers for Tracking Progression

Repeated MRI scans are the standard way to track white matter lesion progression, but they are expensive and not always practical. Researchers have been investigating whether a blood test could serve as a simpler proxy. The leading candidate is neurofilament light chain, a protein released into the bloodstream when nerve fibers are damaged. Higher baseline levels of this protein have been associated with faster progression of white matter lesions over time, and rising levels predicted future growth of lesion volume.

29PubMed. Plasma Neurofilament Light and Longitudinal Progression of White Matter Hyperintensity in Elderly Persons Without Dementia

A separate study found that higher baseline neurofilament light chain levels tripled the odds of lesion progression and were also associated with cognitive decline, with part of the cognitive effect being mediated through the lesion growth itself. In the cognitively impaired subgroup, the odds of progression were even higher, at roughly fivefold.

30Cerebral Circulation – Cognition and Behavior. Plasma neurofilament light chain as a prognostic biomarker of white matter hyperintensity progression and cognitive decline

This biomarker is not yet ready for routine clinical use in monitoring white matter disease specifically, but it is already being adopted in other neurological conditions and may eventually make it possible to track small vessel disease progression without repeated imaging. For now, the practical implication is that if you have white matter lesions and your doctor is deciding how aggressively to manage risk factors, the trajectory of those lesions over time, whether measured by imaging or eventually by blood tests, is becoming an increasingly important part of the conversation.